학술논문
Communicating Immunogenicity-Associated Risk in Current U.S. FDA Prescription Drug Labeling: A Systematic Evaluation
Document Type
Article
Author
Source
In: Therapeutic Innovation and Regulatory Science . (Therapeutic Innovation and Regulatory Science, November 2020, 54(6):1363-1371)
Subject
Language
English
ISSN
21684804
21684790
21684790